Association of β2-adrenoreceptor variants with bronchial hyperresponsiveness

被引:53
|
作者
Ulbrecht, M
Hergeth, MT
Wjst, M
Heinrich, J
Bickeböller, H
Wichmann, HE
Weiss, EH
机构
[1] Univ Munich, Inst Anthropol & Human Genet, D-80333 Munich, Germany
[2] GSF Forschungszentrum Umwelt & Gesundheit GMBH, Inst Epidemiol, Oberschleissheim, Germany
[3] Tech Univ Munich, Inst Med Stat & Epidemiol, D-8000 Munich, Germany
关键词
D O I
10.1164/ajrccm.161.2.9902072
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Because of its involvement in the regulation of airway tone, the beta(2)-adrenoreceptor is considered a candidate for bronchial hyperresponsiveness (BHR) associated with asthma. This notion is supported by several reports that have implicated the chromosomal region 5q31-q33 harboring the gene for the beta(2)-adrenoreceptor in the genetics of asthma and related phenotypes. We performed a population-based association study focusing on BHR as a qualitative trait and omitting other asthma-related phenotypes. From a German population sample of 1,150 individuals we extracted all 152 bronchohyperreactive probands, who were compared with 295 bronchonormoreactive control subjects. All individuals were genotyped for three single nucleotide polymorphisms of the beta(2)-adrenoreceptor gene resulting in variants at the amino acid positions 16, 27, and 164. The genotyping protocol used allowed the determination of haplotypes of these polymorphisms. Whereas no individual polymorphism was associated with BHR, the Gly16/Gln27/Th164 haplotype was significantly underrepresented in the case group indicating a protective effect of this haplotype with regard to BHR. Upon reanalysis by sex a significant association persisted only for female probands.
引用
收藏
页码:469 / 474
页数:6
相关论文
共 50 条
  • [41] Effects of antidepressant treatment on alpha 2-adrenoreceptor function in depressed patients
    Duval, F
    Mokrani, MC
    Monreal, J
    Bailey, P
    Hamel, B
    Macher, JP
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S194 - S194
  • [42] Structural equilibrium underlying ligand-dependent activation of β2-adrenoreceptor
    Shunsuke Imai
    Tomoki Yokomizo
    Yutaka Kofuku
    Yutaro Shiraishi
    Takumi Ueda
    Ichio Shimada
    Nature Chemical Biology, 2020, 16 : 430 - 439
  • [43] α2-adrenoreceptor antagonism and serotonin reuptake inhibition in patients with Parkinson disease and depression
    Årsland, D
    Larsen, JP
    Lim, NG
    Wermuth, L
    Bech, P
    NORDIC JOURNAL OF PSYCHIATRY, 2000, 54 (06) : 411 - 415
  • [44] Comparative In Vitro Study of Various α2-Adrenoreceptor Agonist Drugs for Ticagrelor Reversal
    Bonete, Guillaume Porta
    Godier, Anne
    Gaussem, Pascale
    Belleville-Rolland, Tiphaine
    Leuci, Alexandre
    Poirault-Chassac, Sonia
    Bachelot-Loza, Christilla
    Martin, Anne-Celine
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [45] Dose-dependent association of smoking and bronchial hyperresponsiveness
    Juusela, Maria
    Pallasaho, Paula
    Ronmark, Eva
    Sarna, Seppo
    Sovijarvi, Anssi
    Lundback, Bo
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) : 1503 - 1512
  • [46] Peracute Myocardial Infarction: Features of the Influence of α2-Adrenoreceptor Stimulation on the Isolated Heart
    Kuptsova, A. M.
    Bugrov, R. K.
    Ziyatdinova, N. I.
    Zefirov, T. L.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2024, 176 (03) : 342 - 346
  • [47] Peracute Myocardial Infarction: Features of the Influence of α2-Adrenoreceptor Stimulation on the Isolated Heart
    A. M. Kuptsova
    R. K. Bugrov
    N. I. Ziyatdinova
    T. L. Zefirov
    Bulletin of Experimental Biology and Medicine, 2024, 176 : 315 - 320
  • [48] β2-Adrenoreceptor Agonist Inhibits Antigen Cross-Presentation by Dendritic Cells
    Herve, Julie
    Dubreil, Laurence
    Tardif, Virginie
    Terme, Mickael
    Pogu, Sylvie
    Anegon, Ignacio
    Rozec, Bertrand
    Gauthier, Chantal
    Bach, Jean-Marie
    Blancou, Philippe
    JOURNAL OF IMMUNOLOGY, 2013, 190 (07): : 3163 - 3171
  • [49] β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease
    Mittal, Shuchi
    Bjornevik, Kjetil
    Im, Doo Soon
    Flierl, Adrian
    Dong, Xianjun
    Locascio, Joseph J.
    Abo, Kristine M.
    Long, Elizabeth
    Jin, Ming
    Xu, Bing
    Xiang, Yang K.
    Rochet, Jean-Christophe
    Engeland, Anders
    Rizzu, Patrizia
    Heutink, Peter
    Bartels, Tim
    Selkoe, Dennis J.
    Caldarone, Barbara J.
    Glicksman, Marcie A.
    Khurana, Vikram
    Schule, Birgitt
    Park, David S.
    Riise, Trond
    Scherzer, Clemens R.
    SCIENCE, 2017, 357 (6354) : 891 - 897
  • [50] Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson's disease
    hopfner, F.
    Wod, M.
    Hoeglinger, G.
    Blaabjerg, M.
    Roesler, T.
    Kuhlenbaeumer, G.
    Christensen, K.
    Deuschl, G.
    Pottegard, A.
    MOVEMENT DISORDERS, 2019, 34 : S744 - S746